Basic Information
ID: ALA5225075
Type: Functional
Description: Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as inhibition of plaque formation pretreated for 1 hr followed by viral infection and measured 24 hrs post infection
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA5223130
Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as inhibition of plaque formation pretreated for 1 hr followed by viral infection and measured 24 hrs post infection: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5225075
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 464.50 | 1.86 | 1.86 |
| 452.56 | 2.45 | 2.45 |